Clovis Oncology Inc. (CLVS) gained 13.51% or 3.52 to $29.57. It is near to 2.38 million shares traded, which is 134.92% compare to the average total volume 1.76 million. The market cap of CLVS is $1.56 billion. The year to date change is 47.86%. The 52 week price range is from $11.5 to $65.24. Price of CLVS have changed 7.47% during last week. It have changed 5.42% over last month, 56.83% over last 3 months, -27.64% over last 6 months and -55.96% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CLVS is 22.74. It is -23.10% below current price. The 200-day Moving Averages for CLVS is 31.95. It is 8.05% above current price. The 52-week High is 65.24. It is 120.63% from the current price. The 52-week Low is 11.5. It is -61.11% from current price.
There are some statistics of CLVS. It is has market cap $1.56 billion. The share outstanding is 52.71 million. The average volume is 1.76 million. The percent of top 15 Institution holding is 149.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CLVS is -120.35%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CLVS is -37.79%.